Research3 sources

Prospective and genetic analyses implicate lower immunosurveillance in the aetiology of prostate cancer

Nature · By Mahboubeh Parsaeian · 13h ago

The Brief · written from 3 sources

A study led by researchers at Oxford Population Health links higher levels of immune-activating and coordinating proteins with lower risk of developing prostate cancer.
The findings are published in Nature Communications (doi:10.1038/s41467-026-77378-3) and combine prospective and genetic analyses.
The authors suggest reduced immunosurveillance may play a role in prostate cancer development.

Why it matters

The results point to the immune system as a possible target for prostate cancer prevention, a question that remains open and is not yet a clinical recommendation.

Who’s affected

prostate cancer researchers
clinicians and men concerned about prostate cancer risk

#prostate cancer
#immune system
#immunosurveillance
#cancer prevention
#proteomics

Nature Communications, Published online: 10 November 2026; doi:10.1038/s41467-026-77378-3 Role of specific immune and inflammation-related pathways and protein markers in the development of prostate cancer remains to be elucidated. Here the authors show evidence for potential…

Read the full story at nature.com ↗